Treatment of breakthrough and prevention of refractory chemotherapy-induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update


This CPG is an update of the 2016 version. It aims to provide clinicians (physicians, nurse practitioners, physician assistants, nurses, pharmacists, and others) who care for children and adolescents with cancer or undergoing HSCT with up-to-date recommendations for treatment of breakthrough and prevention of refractory CINV.

Related Guidance


View our guidance library

Explore guidance for providing optimal supportive care to children receiving cancer treatments or undergoing bone marrow transplant.

Stay connected

Sign up to receive the iPOG Network quarterly newsletter!